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A hydroxyl radical-generating system, hypoxanthine/xanthine oxidase/Fe-EDTA, oxidises uroporphyrinogens to uro- 
porphyrins and to more polar nonporphyrin products. The evidence suggests that the nonporphyrin products have in- 
hibitory activity towards mouse liver uroporphyrinogen decarboxylase which could explain some forms of human and 
experimental porphyrias. 
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1. INTRODUCTION 
Human sporadic porphyria cutanea tarda and 
porphyria caused by some chemicals in man and 
rodents, are characterised by inhibition of hepatic 
uroporphyrinogen decarboxylase [ 1,2]. The 
mechanism is unknown but recently favoured 
theories invoke reactive oxygen species generated 
from an uncoupled microsomal system [3-81. The 
oxidation of uroporphyrinogen to uroporphyrin 
occurs with chick embryo liver microsomes in the 
presence of NADPH and 3,4,3’ ,4’ -tetrachlorobi- 
phenyl [6,8] and could account for the accumula- 
tion of uroporphyrin in some experimental systems 
[3,9]. However, it has been proposed that in mam- 
mals treated with porphyrogenic chemicals a 
modified uroporphyrinogen or uroporphyrin may 
be formed which subsequently inhibits the decar- 
boxylase [5,8,10]. As a model we have examined 
the effects of the hypoxanthine/xanthine ox- 
idase/Fe-EDTA hydroxyl radical-generating sys- 
tem [ 1 l-131 on uroporphyrinogens and deter- 
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mined whether products, besides uroporphyrin, 
were formed that inhibited uroporphyrinogen 
decarboxylase. 
2. EXPERIMENTAL 
Specialized chemicals were purchased from the following 
sources: desferrioxamine mesylate, Ciba-Geigy, Switzerland; 
uroporphyrins I and III, pentacarboxyporphyrin I and hydrox- 
ymethylbilane, Porphyrin Products, USA; mouse liver catalase 
(5400 U/mg), bovine kidney superoxide dismutase (10000 
U/mg), butter milk xanthine oxidase (0.9 U/mg) and hypoxan- 
thine, Sigma, England. [%]Uroporphyrin (a mixture of the I 
and III isomers) was as previously described [14]. Por- 
phyrinogens were prepared by Na-amalgam reduction of por- 
phyrins [14]. Solutions were prepared with double glass-distilled 
water which was further purified though a Millipore deionizer. 
Basic incubation mixtures contained 0.5 mM hypoxanthine 
and 0.12 M sodium phosphate buffer (pH 7.4) in a final volume 
of 2.5 ml. When appropriate a Fe’+-EDTA mixture was added 
(final concentrations 0.05 and 0.15 mM, respectively) and xan- 
thine oxidase (0.2 U/ml). Incubations were initiated by the ad- 
dition of uroporphyrinogen (final concentration 3.3 yM) and 
continued at 22°C in the dark. Absorption spectra of incuba- 
tions were determined at the end of experiments and sometimes 
at more frequent intervals. Enough 0.1 M iodine solution in KI 
was then added to oxidise any remaining uroporphyrinogen un- 
til there was no further increase in the Soret peak. Fluorescence 
spectroscopy was performed as described by Granick et al. [15]. 
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Reverse-phase HPLC of uroporphyrin was carried out as in 
[16]. Incubations with [‘?]uroporphyrinogen were treated as 
above except hat fractions were collected after HPLC and 
radioactivity contents then determined. Inhibition of uropor- 
phyrinogen decarboxylase activity after preincubation with 
products of uroporphyrinogen oxidation was estimated using 
pentacarboxyporphyrinogen 1 as substrate and 40000 xg 
C57BL/IOScSn mouse liver supernatant as the enzyme source 
[16,17]. 
3. RESULTS 
3.1. Oxidation of uroporphyrinogens 
In the presence of hypoxanthineixanthine ox- 
idase/Fe-EDTA, uroporphyrinogen III was rapid- 
ly oxidised to uroporphyrin (fig.1). Without iron 
or xanthine oxidase the conversion of uropor- 
phyrinogen to uroporphyrin was much reduced in- 
dicating a probable involvement of hydroxyl 
radical. The same conclusion was suggested by the 
protective effects of catalase, mannitol and desfer- 
rioxamine although superoxide dismutase did not 
protect and instead consistently gave enhanced 
porphyrin formation (table 1). Both uropor- 
phyrinogens I and III were oxidised. In addition, 
oxidation to nonporphyrin products occurred, 
since after careful reoxidation of remaining por- 
phyrinogen with iodine, the final yield of uropor- 
phyrin recovered was significantly lower in 
incubations with xanthine oxidase/Fe-EDTA 
whether this was estimated from the absorption 
spectrum or by HPLC (table 2). No major addi- 
tional peaks during HPLC could be detected when 
monitoring for porphyrins at 400 nm to account 
for this loss. Both catalase and superoxide 
dismutase partially protected from the reduction in 
yield (not shown). Fluorescence spectroscopy also 
illustrated a reduced yield of recovered porphyrin 
after treatment of uroporphyrinogen III for 30 min 
with hydroxyl radical, i.e. relative fluorescence, 
control 100; xanthine oxidase/Fe-EDTA, 67. 
Uroporphyrins were only slowly affected by 
hydroxyl radical (< 7% in 30 min) when compared 
with porphyrinogens whether this was assessed by 
absorption spectroscopy (fig. I), fluorescence spec- 
troscopy or HPLC. 
Hydroxymethylbilane was also oxidised to uro- 
porphyrin I at an increased rate (150% of control) 
by incubation with xanthine oxidase/Fe-EDTA 
with a decreased yield of recovered porphyrin 
(75%) as estimated by absorption spectroscopy 
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Fig.]. Oxidation of uroporphyrinogen III (3.3 PM) in the 
presence of the hypoxanthine/xanthine oxidase (X.O)/Fe- 
EDTA hydroxyl radical-generating system. 
and HPLC. Whether hydroxymethylbilane itself 
was attacked or the uroporphyrinogen formed 
from it was not determined. 
3.2. Oxidation of f4CJuroporphyrinogen 
[‘4C]Uroporphyrinogen was oxidised by xan- 
thine oxidase/Fe-EDTA and the recovered prod- 
ucts were examined by estimating radioactivity 
contents of fractions following HPLC (fig.2). The 
radioactivity associated with uroporphyrin was 
reduced to 64% of control whereas that of frac- 
tions 1-7, corresponding to polar products, was in- 
creased > 5-fold (fig.2A,D). No additional peaks 
absorbing at 400 nm were observed to account for 
Table 1 
Effects of scavengers on uroporphyrinogen III oxidation to 
uroporphyrin 
Conditions nmol uroporphyrin % protection 
formed/30 min 
Basic 
+ superoxide dismutase 
(100 U/ml) 
+ catalase (200 U/ml)” 
+ desferrioxamine (0.5 
mM) 
+ mannitol (10 mM) 
4.2 - 
4.9 -17 
I.6 62 
2.5 40 
2.6 38 
a Greater quantities of catalase afforded only slight additional 
protection 
Incubations contained hypoxanthine, xanthine oxidase, Fe- 
EDTA and uroporphyrinogen III as described in section 2. 
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Table 2 
Oxidation of uroporphyrinogens I and III and recovery of uroporphyrins 
Conditions” Uroporphyrin formed 
in 30 minb 
(nmol) 
I III 
Control 0.1 0.1 
Fe-EDTA 0.5 0.2 
x.0. 1.6 0.4 
X.0. + Fe-EDTA 4.4 3.9 
Recovery of uroporphyrinC 
a Conditions were as described in section 2 
b Uroporphyrin formation was estimated from the Soret peak in the absorption spectrum 
’ Estimated after gentle oxidation with iodine solution of any uroporphyrinogen remaining 
this increased radioactivity (fig.2E,F) again sug- 
gesting that the polar oxidation products did not 
contain the porphyrin aromatic system. Catalase 
and superoxide dismutase decreased radioactivity 
present in fractions l-7 by 90 and 75% respective- 
By Soret By HPLC 
(nmol) (relative) 
I III I III 
7.3 6.7 100 100 
6.8 6.0 99 106 
5.6 4.8 67 71 
4.5 3.7 55 46 
I5 30 0 15 30 
I!; X.0 Ti _I: xo+L 
0 15 30 0 I5 30 
one ml” rractlon ““mbers 
IEI Control I IFI x.0 +Fe 
a 15 30 a 15 30 
Time imbnl 
Fig.2. HPLC of incubations of [“Cluroporphyrinogen with 
hypoxanthine/xanthine oxidase (X.O.)/Fe-EDTA. 
ly, when included in xanthine oxidase/Fe-EDTA 
incubations. 
3.3. Incubation of uroporphyrinogen 
decarboxylase 
Aliquots from incubations of uroporphyrinogen 
III with the hydroxyl radical-producing systems 
hypoxanthine/xanthine oxidase/Fe-EDTA and 
H20JFe-EDTA caused a modest but consistent 
inhibition of uroporphyrinogen decarboxylase ac- 
Table 3 
Inhibition of uroporphyrinogen decarboxylase 
Conditions Relative decarboxy- 
lase activity 
Expt A 
X.0. + Fe-EDTA 
X.0. + Fe-EDTA + uroporphyrin III 
X.0. + Fe-EDTA + uroporphyrinogen 
III 
100 
95 
62 
Expt B 
Hz02 + Fe-EDTA 100 
Hz01 + Fe-EDTA-uroporphyrin III 73 
Ha02 + Fe-EDTA-uroporphyrinogen 
III 51 
Incubations with xanthine oxidase (X.0.) + Fe’+-EDTA (expt 
A) were as described in section 2 whereas those with Ha02 (0.3 
mM) contained Fe’+-EDTA (expt B). After 30 min at 22°C 
these incubations were stopped with iodine and an aliquot (0.2 
ml) incubated with C57BL/IOScSn mouse liver 4OOOOxg 
supernatant for IO min at 37°C 1201. Residual uroporphyrino- 
gen decarboxylase activity was then determined using penta- 
carboxyporphyrinogen I as the substrate [20]. The final 
concentration of uroporphyrin- or uroporphyrinogen-derived 
matieral in a decarboxylase assay was 0.66 pM 
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tivity (table 3). This was neither due to interference 
from uroporphyrinogen nor to uroporphyrin [17]. 
Inhibition was significantly less if uroporphyrin III 
replaced uroporphyrinogen III in the oxidation 
system. 
4. DISCUSSION 
It appears that hydroxyl radicals (or related 
iron-oxygen species) can oxidise uroporphyrinogen 
to uroporphyrin. Perhaps more importantly, side 
products of greater polarity are formed that can- 
not regain the porphyrin structure. It is interesting, 
however, that although superoxide dismutase 
decreased the amount of side products formed it 
enhanced uroporphyrin formation which may im- 
ply that ‘softer’ oxidising species were produced 
capable of abstracting hydrogen from. uropor- 
phyrinogen but incapable of inserting oxygen func- 
tions. Variations in such a balance of oxidising 
species may have parallels in isolated hepatocytes 
and in vivo. Not surprisingly, hydroxymethylbi- 
lane (the biosynthetic precursor of uropor- 
phyrinogens [18]) is also attacked by hydroxyl 
radicals. 
The hypothesis that some modified por- 
phyrinogens are responsible for uroporphyrinogen 
decarboxylase inhibition in vivo is supported by 
the data in table 3. Although inhibitions observed 
were moderate, it is worth noting that the total 
products in the assays were in the nanomolar range 
and in vivo oxidations might well be considerably 
more selective. Studies are in progress to examine 
polar products of uroporphyrinogen oxidation and 
to explore any similarities with the inhibitor of 
uroporphyrinogen decarboxylase detected in 
mouse liver after treatment of animals with various 
aromatic drugs and environmental chemicals 
[5,19,20]. 
REFERENCES 
[II 
I21 
131 
[41 
151 
161 
171 
PI 
191 
IlO1 
[Ill 
iI-21 
1131 
iI41 
[151 
[I61 
[I71 
P81 
1191 
WI 
Marks, G.S. (1985) Crit. Rev. Toxicol. 15, 151-179. 
Sweeney, G.D. (1986) Clin. Biochem. 19, 3-15. 
Ferioli, A., Harvey, C. and De Matteis, F. (1984) 
Biochem. J. 224, 769-777. 
Sweeney, G., Basford, D., Rowley, B. and Goddard, G. 
(1984) Banbury Rep. 18, 225-237. 
Francis, J.E. and Smith, A.G. (1987) Biochem. Biophys. 
Res. Commun. 146, 13-20. 
Sinclair, P., Lambrecht, R. and Sinclair, J. (1987) Bio- 
them. Biophys. Res. Commun. 146, 1324-1329. 
Urquhart, A.J. and Elder, G.H. (1987) Biochem. 
Pharmacol. 36, 3795-3796. 
De Matteis, F., Harvey, C., Reed, C. and Hempenius, R. 
(1988) Biochem. J. 250, 161-169. 
Sinclair, P.R., Bement, W.J., Bonkovsky, H.L., 
Lambrecht, R.W., Frezza, J.E., Sinclair, J.F., Urquhart, 
A.J. and Elder, G.H. (1986) Biochem. J. 237, 63-71. 
Smith, A.G. and Francis, J.E. (1988) in: Proceedings of 
the International Meeting Porphyrins and Porphyrias 
(Topi, G.C. ed.) Rome 1987, in press. 
McCord, J.M. and Day, E.D. (1975) FEBS Lett. 86, 
139-142. 
Halliwell, B. and Gutteridge, J.M.C. (1984) Biochem. J. 
219, t-14. 
Aust, S.D., Morehause, L.A. and Thomas, C.E. (1985) J. 
Free Radical Biol. Med. 1,3-25. 
Smith, A.G. and Francis, J.E. (1981) Biochem. J. 195, 
241-250. 
Granick, S., Sinclair, P., Sassa, S. and Grieninger, G. 
(1975) J. Biol. Chem. 250, 9215-9225. 
Francis, J.E. and Smith, A.G. (1984) Anal. Biochem. 138, 
404-410. 
Smith, A.G., Francis, J.E., Kay, S.J.E., Greig, J.B. and 
Stewart, F.P. (1986) Biochem. J. 238, 871-878. 
Battersby, A.R., Fookes, C.J.R., Gustafson-Potter, K.E., 
McDonald, E. and Matcham, G.W.J. (1982) J. Chem. 
Sot. Perkin Trans. I, 2427-2444. 
Cantoni, L., Dal Fiume, D., Rizzardini, M. and Ruggieri, 
R. (1984) Toxicol. Lett. 20, 211-217. 
Smith, A.G. and Francis, J.E. (1987) Biochem. J. 246, 
221-226. 
314 
